EVE TRIAL , ALMA SYSTAM

IsraelRecruitingPHASE3

Conditions

Postpartum Haemorrhage (PPH) · PPH · Postpartum Hemorrhage (Primary)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Maimonides Medical Center | Brooklyn, New York Hospital, Brooklyn, New York, United States
Contact: Study coordinator (Itamar Futterman, MD) · ifutterman@maimo.org · 9179220515
Shaare Zedek Medical Center, Jerusalem, Israel
Contact: Study coordinator (Hen Sela, MD) · hysela@szmc.org.il · 972-507874676

Study leads

Scott Chudnoff, MD
Study Chair
Maimonides Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)

Pre-eclampsia · Oocyte Donation · Pre-Eclampsia; Complicating Pregnancy

Abroad (travel likely)Recruiting

Copenhagen, Denmark · Hellerup, Denmark

Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia.

Thrombocytopenia · Postpartum Haemorrhage (PPH)

Abroad (travel likely)Recruiting

Madrid, Spain

Postpartum Hemorrhage Reduction With Oral Tranexamic Acid: a Clinical Trial

PPH

Abroad (travel likely)RecruitingPHASE4

Stockholm, Sweden

Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery

Cesarean Delivery · Postpartum Hemorrhage (PPH) · Intraoperative Blood Loss

IsraelRecruitingEARLY_PHASE1

Holon, Israel · Kfar Saba, Israel